Johannes Fosselteder

Graz, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Mutant TP53 allelic states in human hematopoietic stem and progenitor cells.

Mutant TP53 allelic states in human hematopoietic stem and progenitor cells.

Journal: Leukemia
Published: February 16, 2026

Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib Sensitivity.

Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib Sensitivity.

Journal: Blood
Published: December 09, 2024

Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity.

Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity.

Journal: Blood
Published: December 09, 2024

Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells.

Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells.

Journal: Experimental hematology
Published: September 13, 2024

Langerhans cell histiocytosis: current advances in molecular pathogenesis.

Langerhans cell histiocytosis: current advances in molecular pathogenesis.

Journal: Frontiers in immunology
Published: August 09, 2023

BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis.

BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis.

Journal: Leukemia
Published: May 02, 2023

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells.

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells.

Journal: Journal of visualized experiments : JoVE
Published: March 27, 2023

Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.

Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.

Journal: Leukemia
Published: July 19, 2022

Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms.

Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms.

Journal: Bio-protocol
Published: June 14, 2022

Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.

Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.

Journal: EMBO reports
Published: June 10, 2021

Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi.

Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi.

Journal: Genome research
Published: April 05, 2021

Deficiency of malate-aspartate shuttle component SLC25A12 induces pulmonary metastasis.

Deficiency of malate-aspartate shuttle component SLC25A12 induces pulmonary metastasis.

Journal: Cancer & metabolism
Published: May 11, 2020
Showing 1-12 of 16

Last Updated: 09/26/2026